Study of the secretion of atrial natriuretic peptide (ANP) induced by morphine.

吗啡诱导心房钠尿肽(ANP)分泌的研究。

基本信息

  • 批准号:
    63570717
  • 负责人:
  • 金额:
    $ 0.96万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1989
  • 项目状态:
    已结题

项目摘要

1)In vivo experiment: Effects of morphine, feritanyl, dynorphin, enkepharin, beta-endorphin and naloxone on immunoreactive atrial natriuretic peptide (ir-ANP) levels in the plasma were investigated in conscious and unstrained male wistar rats. High dose of morphine and fentanyl induced a significant increase in plasma levels of ir-ANP concentration, but none of other opioide peptides induced such a increase. Significant increases in plasma cyclic GMP levels as well as ir-ANP were observed in morphine and fentanyl groups. Cyclic GMP was strongly implicated as a second messenger for ir-ANP. The increase in plasma cyclic GMP was well correlated with the increase of plasma ir-ANP levels. These significant increases were completely blocked by naloxone which was a strong, antagonist to opiate receptor of mu type. These results suggest that a high dose of morphine would increase plasma ir-ANP via morphine receptor. Furthermore, the marked increases of plasma catecholamine (NE and E) were observed as well as ir-ANP and cGMP by morphine and fentanyl. This observation would indicate a possible involvement of endogeneous catecholamine with opiate receptor in the reguration of ir-ANP secretion.2)In vitro experiment: The rat atrium cells were obtained by the enzyme dissociation of atrium. The cells were incubated with opioide peptides and catecholamines under the condition of 95% O and 5% CO with 38 C for 4 h. The concentration of ir-ANP in medium of culture tubes were increased by dynorphin and catecholamine but not another peptide. The combination of dynorphin and catecholamine markedly increased ir-ANP secretion from atrium cells, Especially. the combination with dopamine induced 10 fold increase than that of NE and E. These increase in ir-ANP were not blocked by naloxone.These results from the experiments of in vivo and in vitro suggest that endogeneous catecholamines involved in the secretion of ANP induced by large dose of morphine.
1)体内实验:在有意识和未经训练的雄性Wistar Rats中研究了吗啡,Feritanyl,dynorphin,ankepharin,Enkepharin,beta-Endorphin和Naloxone对血浆中质量下的免疫反应性心房肽(IR-ANP)水平的影响。高剂量的吗啡和芬太尼诱导了IR-ANP浓度的血浆水平显着升高,但其他阿片类肽都没有诱导这种增加。在吗啡和芬太尼基团中观察到血浆周期GMP水平以及IR-ANP的显着增加。循环GMP强烈牵涉到IR-ANP的第二个使者。等离子体周期GMP的增加与血浆IR-ANP水平的增加相关。这些显着增加被纳洛酮完全阻断,纳洛酮是对MU类型的阿片类药物受体的强大拮抗剂。这些结果表明,高剂量的吗啡会通过吗啡受体增加血浆IR-ANP。此外,吗啡和芬太尼观察到了血浆儿茶酚胺(NE和E)的显着增加以及IR-ANP和CGMP。该观察结果将表明内差儿茶酚胺与鸦片受体可能涉及IR-ANP分泌的回流。2)体外实验:大鼠心房细胞是通过心房的酶解离而获得的。将细胞与阿片类肽和儿茶酚胺一起在95%O和5%CO的情况下与38 C孵育4小时。 dynorphin和Catecholamine增加了IR-ANP在培养管培养基中的浓度,但不是另一种肽。特尼酚和儿茶酚胺的组合显着增加了中庭细胞的IR-ANP分泌,尤其是。与多巴胺诱导的10倍相比,IR-ANP中的增长并未被纳洛酮阻塞。这些来自体内的实验和体外的结果表明,内源性儿茶酚胺与大剂量的大剂量诱导的ANP分泌有关。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tsuyoshi Kudo: "Effects of intravenous anesthetics and analgesic on plasma alpha-rat atrial natriuretic peptide (alpha-rANP) levels in rats" Japan.J.Anesthesiology 38; (7)901-907, 1989.
Tsuyoshi Kudo:“静脉麻醉药和镇痛药对大鼠血浆 α-大鼠心房钠尿肽 (α-rANP) 水平的影响”Japan.J.Anesthesiology 38;
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
工藤美穂子: "出血による低血圧時の血中心房性ナトリウム利尿ポリペプチド濃度に及ぼすデキサメタゾン、ACTHの影響" 麻酔. 38. 1323-1328 (1989)
Mihoko Kudo:“失血性低血压期间地塞米松和 ACTH 对心房钠尿多肽浓度的影响”麻醉,38。1323-1328 (1989)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
工藤剛: 麻酔. 38. (1989)
工藤刚:《麻醉》38。(1989)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mihoko Kudo: "Effect of dexamethazone and ACTH on plasma atrial natriuretic polypeptide levels during hemorrhage in rats" Japan.J.Anesthesiology 38; (10)1323-1328, 1989.
Mihoko Kudo:“地塞米松和 ACTH 对大鼠出血期间血浆心房钠尿多肽水平的影响”Japan.J.Anesthesiology 38;
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsuyoshi Kudo: "Opiate Receptor Modifies Secretion of Immunoreactive Atrial Natriuretic Peptide Inducea by Morphine in Rat" J.of Neuroendocrinology.
Tsuyoshi Kudo:“阿片受体通过吗啡诱导大鼠改变免疫反应性心房钠尿肽的分泌”J.of Neuroendocrinology。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUDO Tsuyoshi其他文献

KUDO Tsuyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUDO Tsuyoshi', 18)}}的其他基金

Studies of Pharmacokinetic on Enatiomers of Ketamine and Norketamine during DFK Anesthesia
DFK麻醉中氯胺酮和去甲氯胺酮对映体的药动学研究
  • 批准号:
    07671639
  • 财政年份:
    1995
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Atg5/Atg7依赖的自噬参与吗啡镇痛耐受的分子机制研究
  • 批准号:
    32360169
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    地区科学基金项目
小脑皮层浦肯野细胞不同来源的兴奋性输入在吗啡条件性位置偏爱中的作用及机制研究
  • 批准号:
    82360274
  • 批准年份:
    2023
  • 资助金额:
    32.2 万元
  • 项目类别:
    地区科学基金项目
HINT1蛋白调节μ阿片受体去SUMO化修饰在吗啡成瘾中的作用及可塑性机制研究
  • 批准号:
    82301678
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
NEFL/NRN1通路介导自噬在二乙酰吗啡致神经元凋亡中的作用及机制研究
  • 批准号:
    82360256
  • 批准年份:
    2023
  • 资助金额:
    32.2 万元
  • 项目类别:
    地区科学基金项目
ATF4抑制DRG神经元MOR膜转位介导吗啡镇痛耐受的机制研究
  • 批准号:
    82271241
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目

相似海外基金

March5 and Associated Mitochondrial Dynamics in Incubation of Oxycodone Craving
March5 和相关线粒体动力学在羟考酮渴望孵化中的作用
  • 批准号:
    10724668
  • 财政年份:
    2023
  • 资助金额:
    $ 0.96万
  • 项目类别:
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
  • 批准号:
    10726834
  • 财政年份:
    2023
  • 资助金额:
    $ 0.96万
  • 项目类别:
Synthetic Scavenger Medical Countermeasures for Fentanyl
芬太尼的合成清除剂医疗对策
  • 批准号:
    10726539
  • 财政年份:
    2023
  • 资助金额:
    $ 0.96万
  • 项目类别:
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
  • 批准号:
    10584712
  • 财政年份:
    2023
  • 资助金额:
    $ 0.96万
  • 项目类别:
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
  • 批准号:
    10678062
  • 财政年份:
    2023
  • 资助金额:
    $ 0.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了